Evidence map›Paper›PMID 38834847›Full record

Trial reportNature medicine2024

Non-literacy biased, culturally fair cognitive detection tool in primary care patients with cognitive concerns: a randomized controlled trial.

Joe Verghese, Rachel Chalmer, Marnina Stimmel, Erica Weiss, Jessica Zwerling, Rubina Malik, David Rasekh, Asif Ansari, Roderick A Corriveau, Amy R Ehrlich and 2 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nature medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03816644 (5-Cog Battery to Improve Detection of Cognitive Impairment and Dementia), which is not on this map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03816644 nacompletednot on this map

5-Cog Battery to Improve Detection of Cognitive Impairment and Dementia

TypeinterventionalSponsorAlbert Einstein College of MedicineRan2019 to 2023Enrolled1,201ConditionsDementia, Cognitive Impairment, Mild Cognitive Impairment, Neurocognitive DisordersArms5-Cog, Health Literacy & Grip Assessment
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Article
  8. Article
  9. Role of PCPs in diagnosing dementia in traditional Medicare and Medicare Advantage.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Observational
  10. Enhancing early detection of cognitive impairment in primary care with the TabCAT-BHA.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Joe VergheseDepartments of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA. joe.verghese@einsteinmed.edu.ORCID 0000-0003-4252-2547
Rachel ChalmerDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.
Marnina StimmelDepartments of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA.
Erica WeissDepartments of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA.ORCID 0000-0002-0726-7547
Jessica ZwerlingDepartments of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA.
Rubina MalikDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.
David RasekhDepartment of Medicine, Montefiore Medical Center, Bronx, NY, USA.
Asif AnsariDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.
Roderick A CorriveauDepartment of Neuroscience, National Institute of Neurological Disorders and Stroke, Bethesda, MA, USA.ORCID 0000-0002-6954-9240
Amy R EhrlichDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.
Cuiling WangDepartment of Medicine, Montefiore Medical Center, Bronx, NY, USA.
Emmeline AyersDepartments of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA.

Funding

5-Cog Paradigm to Improve Detection of Cognitive Impairment in Primary Care: Pragmatic Clinical TrialU01NS105565 · NINDS · STATE UNIVERSITY NEW YORK STONY BROOK · PI MALAZ BOUSTANI, JOE VERGHESE · 2022 to 2026
$6.3M
5-Cog Battery to improve detection of cognitive impairment and dementiaUG3NS105565 · NINDS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI VERGHESE, JOE · 2017 to 2018
$1.4M
NINDS NIH HHS U01 NS105565NINDS NIH HHS UG3 NS105565U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) UG3NS105565 and U01NS105565
6 · The paper itself

Abstract

Dementia is often undiagnosed in primary care, and even when diagnosed, untreated. The 5-Cog paradigm, a brief, culturally adept, cognitive detection tool paired with a clinical decision support may reduce barriers to improving dementia diagnosis and care. We performed a randomized controlled trial in primary care patients experiencing health disparities (racial/ethnic minorities and socioeconomically disadvantaged). Older adults with cognitive concerns were assigned in a 1:1 ratio to the 5-Cog paradigm or control. Primary outcome was improved dementia care actions defined as any of the following endpoints within 90 days: new mild cognitive impairment syndrome or dementia diagnoses as well as investigations, medications or specialist referrals ordered for cognitive indications. Groups were compared using intention-to-treat principles with multivariable logistic regression. Overall, 1,201 patients (mean age 72.8 years, 72% women and 94% Black, Hispanic or Latino) were enrolled and 599 were assigned to 5-Cog and 602 to the control. The 5-Cog paradigm demonstrated threefold odds of improvement in dementia care actions over control (odds ratio 3.43, 95% confidence interval 2.32-5.07). No serious intervention-related adverse events were reported. The 5-Cog paradigm improved diagnosis and management in patients with cognitive concerns and provides evidence to promote practice change to improve dementia care actions in primary care.ClinicalTrials.gov: NCT03816644 .

Indexed as

DementiaPrimary Health CareAgedAged, 80 and overCognitionCognitive DysfunctionFemaleHumansLiteracyMaleMiddle Aged

Identifiers

PMID38834847
PMCPMC11333278

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.